Dawnrays Pharmaceutical Holdings Ltd (2348)

Currency in HKD
0.975
0.000(0.00%)
Closed·
Trading near 52-week Low
High dividend Yield
2348 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9650.975
52 wk Range
0.9651.260
Key Statistics
Bid/Ask
0.965 / 0.975
Prev. Close
0.975
Open
0.975
Day's Range
0.965-0.975
52 wk Range
0.965-1.26
Volume
112K
Average Volume (3m)
149.31K
1-Year Change
-19.4215%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2348 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 28, 2026
EPS / Forecast
0.08 / --
Revenue / Forecast
545.84M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.15%
Dividend Yield
6.46%
Industry Median 2.63%
Annualized payout
0.06
Paid unevenly
5-Years Growth
+0.88%
Growth Streak

2348 Income Statement

Compare 2348 to Peers and Sector

Metrics to compare
2348
Peers
Sector
Relationship
P/E Ratio
5.4x20.0x−0.4x
PEG Ratio
0.180.090.00
Price/Book
0.4x1.4x2.6x
Price / LTM Sales
1.1x2.1x3.1x
Upside (Analyst Target)
-52.9%57.4%
Fair Value Upside
Unlock17.5%7.7%Unlock

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Employees
1074
Market
Hong Kong

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
48.04M3.19%46.84M
Other Institutional Investors
824.74M54.75%804.12M
Public Companies & Retail Investors
633.62M42.06%617.77M
Total
1.51B100.00%1.47B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fortune United Group Limited40.07%603,624,000588,533
Toyo International Investment Limited7.45%112,284,000109,477

FAQ

What Is the Dawnrays Pharma (2348) Stock Price Today?

The Dawnrays Pharma stock price today is 0.975 HKD.

What Stock Exchange Does Dawnrays Pharma Trade On?

Dawnrays Pharma is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Dawnrays Pharma?

The stock symbol for Dawnrays Pharma is "2348."

Does Dawnrays Pharma Pay Dividends? What’s The Current Dividend Yield?

The Dawnrays Pharma dividend yield is 6.46%.

What Is the Dawnrays Pharma Market Cap?

As of today, Dawnrays Pharma market cap is 1.470B HKD.

What Is Dawnrays Pharma's Earnings Per Share (TTM)?

The Dawnrays Pharma EPS (TTM) is 0.152.

From a Technical Analysis Perspective, Is 2348 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dawnrays Pharma Stock Split?

Dawnrays Pharma has split 1 times.

How Many Employees Does Dawnrays Pharma Have?

Dawnrays Pharma has 1074 employees.

What is the current trading status of Dawnrays Pharma (2348)?

As of Sep 28, 2026, Dawnrays Pharma (2348) is trading at a price of 0.975 HKD, with a previous close of 0.975 HKD. The stock has fluctuated within a day range of 0.965 HKD to 0.975 HKD, while its 52-week range spans from 0.965 HKD to 1.260 HKD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.